Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.04.03.716425

Actinomarina, resolved

Abstract

Actinomarina (Ca. Actinomarina minuta) is among the smallest known free-living bacteria and among the most abundant photoheterotrophs in ocean surface waters, yet not a single complete genome has been published for any member of the order Actinomarinales. Here we present 84 complete Actinomarina genomes assembled from Oxford Nanopore metagenomes of the San Francisco Estuary (SFE), together with 29 additional high-quality ([&ge;]95% complete, <5% contamination, single contig) non-circular assemblies. These genomes define 9 species at 95% ANI, three of which are novel, and represent, to our knowledge, the first complete genomes for the entire Actinomarinales order. An expanded phylogeny incorporating 23 high-quality NCBI genomes and a Casp-actino5 outgroup confirms species boundaries and places NCBI genomes among SFE clades. The pangenome of 9,278 clusters is approaching closure (decay ratio 0.55), with a core genome of 227 single-copy genes (2.4%). Singletons (3,858 clusters, 42%) are concentrated in a tRNA-bounded hypervariable region (HVR) at 85-90% of the chromosome from dnaA -- a similar replicative distance to the HVR recently described in Pelagibacter (7-15% from dnaA; Lui & Nielsen, in preparation) but on the opposite replichore. The HVR is flanked by tRNA genes at both boundaries, and in 32 of 84 genomes, the selenocysteine tRNA (selC) is physically located inside the HVR. All 84 genomes encode selenocysteine tRNA (selC) and the selenocysteine biosynthesis genes selA and selD; the elongation factor selB is present but divergent. This has not been previously reported for Actinomarina. Deep learning selenoprotein prediction (deep-Sep) identifies [~]5 selenoproteins per genome in 69 families, including a selenoprotein form of selD itself. Retention of dedicated Sec biosynthetic machinery serving multiple targets in a genome of [~]1.1 Mbp implies that the catalytic advantage of selenocysteine over cysteine is large enough to justify the cost. KofamScan pathway reconstruction reveals the most extensive set of auxotrophies yet documented from complete genomes in a free-living marine bacterium: arginine, histidine, tryptophan, and thiamine biosynthesis are universally absent, biotin biosynthesis is non-functional (final step absent), and only 5 of 8 TCA cycle steps are retained at the standard detection threshold. Gene order is extensively rearranged between species: no gene adjacency is universal across all 84 genomes. NCBI currently lists 396 Actinomarina genomes, none complete; of the 39 that pass quality thresholds, 41% are misclassified by NCBI, belonging to other genera by GTDB-Tk reclassification.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nielsen, T. N., Lui, L. M.. 2026-04-07. Actinomarina, resolved. https://doi.org/10.64898/2026.04.03.716425

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗